Harrow Enters into Agreement to Acquire Exclusive U.S. Rights to ILEVRO®, NEVANAC®, VIGAMOX®, MAXIDEX®, and TRIESENCE®
Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery,...
Read More
Author: Samantha Budd
Shamir Selects IMDT’s 3D Stereo Vision Technology To Power Its Next-generation Digital Measurement Device
Spark™ 4, Shamir’s newest ultra-precise digital measurement device, deploys...
Read More
World Council of Optometry Issues Myopia Management Standard of Care Pledge Challenge
Standard of Care Rests on the Three Pillars of Mitigation, Measurement, and Management The...
Read More
AXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic Test; Files Provisional Patent
Leading Diagnostic Healthcare Company Announces Development of and Provisional Patent Filing on...
Read More